United States · FDA National Drug Code directory
HYALURONIDASE (HUMAN RECOMBINANT)
Source ingredient · 18 source records
Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.
Darzalex Faspro
INJECTION / Janssen Biotech, Inc.
HYALURONIDASE
INJECTION, SOLUTION / HF Acquisition Co LLC, DBA HealthFirst
HYLENEX Recombinant
INJECTION, SOLUTION / Antares Pharma, Inc.
Herceptin Hylecta
INJECTION, SOLUTION / Genentech, Inc.
OPDIVO QVANTIG
INJECTION, SOLUTION / E.R. Squibb & Sons, L.L.C.
OPDIVO QVANTIG
INJECTION, SOLUTION / E.R. Squibb & Sons, L.L.C.
Ocrevus Zunovo
INJECTION, SOLUTION / Genentech, Inc.
Phesgo
INJECTION, SOLUTION / Genentech, Inc.
Phesgo
INJECTION, SOLUTION / Genentech, Inc.
Rituxan Hycela
INJECTION, SOLUTION / Genentech, Inc.
Rituxan Hycela
INJECTION, SOLUTION / Genentech, Inc.
Rybrevant Faspro
INJECTION / Janssen Biotech, Inc.
Rybrevant Faspro
INJECTION / Janssen Biotech, Inc.
Rybrevant Faspro
INJECTION / Janssen Biotech, Inc.
Rybrevant Faspro
INJECTION / Janssen Biotech, Inc.
Tecentriq Hybreza
INJECTION / Genentech, Inc.
VYVGART Hytrulo
INJECTION, SOLUTION / argenx US
VYVGART Hytrulo
INJECTION, SOLUTION / argenx US